Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

DE:JNJ Stock Latest News

The FlyMorning Movers: Novo Nordisk gains after Wegovy pill approved

5d ago

HII

JNJ

PremiumThe Fly

Jury orders Johnson & Johnson to pay over $1.5B in talc case, Reuters says

5d ago

JNJ

KVUE

PremiumThe Fly

Johnson & Johnson issues statement on Craft verdict, intends to appeal

5d ago

JNJ

PremiumThe Fly

Government deals lift overhang on pharma group, says BofA

6d ago

AZN

BMY

PremiumThe Fly

Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports

9d ago

AZN

BMY

PremiumThe FlyJohnson & Johnson announces FDA approval of TRUFILL n-BCA Liquid Embolic System

10d ago

JNJ

Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs

Premium

The Fly

Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs

10d ago

JNJ

Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA

Premium

The Fly

Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA

10d ago

JNJ

HALO

PremiumThe Fly

Johnson & Johnson announces FDA approved Rybrevant in NSCLC patients

10d ago

JNJ

PremiumThe Fly

Johnson & Johnson price target raised to $240 from $230 at RBC Capital

11d ago

JNJ

PremiumThe Fly

Johnson & Johnson price target raised to $220 from $204 at BofA

13d ago

JNJ

PremiumRatings

Balanced Risk-Reward Profile for Johnson & Johnson Amid Limited Stock Re-Rating Potential

13d ago

JNJ

PremiumThe FlyJohnson & Johnson announces FDA approved sNDA for AKEEGA plus prednisone

14d ago

JNJ

FDA approves J&J’s Akeega BRCA2-mutated prostate cancer

Premium

The Fly

FDA approves J&J’s Akeega BRCA2-mutated prostate cancer

15d ago

JNJ

Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley

Premium

The Fly

Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley

16d ago

JNJ

PremiumThe Fly

Johnson & Johnson price target raised to $230 from $209 at RBC Capital

17d ago

JNJ

PremiumThe Fly

Johnson & Johnson price target raised to $232 from $215 at Citi

17d ago

JNJ

PremiumThe Fly

Johnson & Johnson price target raised to $240 from $215 at HSBC

18d ago

JNJ

PremiumRatings

Cautious Hold Rating for Johnson & Johnson Amid Promising Clinical Results and Competitive Challenges

18d ago

JNJ

PremiumThe FlyCarvykti strength holds, Legend Biotech weakness overdone, says RBC Capital

19d ago

JNJ

LEGN

Johnson & Johnson reports results from Phase 3 MajesTEC-3 study

Premium

The Fly

Johnson & Johnson reports results from Phase 3 MajesTEC-3 study

19d ago

JNJ

Eli Lilly, Pfizer, Johnson secure spots on China’s drug catalog, Bloomberg says

Premium

The Fly

Eli Lilly, Pfizer, Johnson secure spots on China’s drug catalog, Bloomberg says

21d ago

JNJ

LLY

DE:JNJ Stock Latest News

Trending

Indices

Stocks

ETFs